Allarity Therapeutics Said on Jan 26 Received Notice From Novartis to Terminate Agreement That Provided Co With the Right to Dovitinib Based on Material Breach for Lack of Financial Payment

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!